key: cord-1015627-qgib1cu4 authors: Rai, Nooralam; Cornett, Joseph A; Zachariah, Philip; Quittell, Lynne; Lovinsky‐Desir, Stephanie title: Severe respiratory viral infections in children with history of asymptomatic or mild COVID‐19 date: 2021-11-15 journal: Pediatr Pulmonol DOI: 10.1002/ppul.25752 sha: 7c81dcfe0fab3f2171c9c1cb6acd5a51b4969917 doc_id: 1015627 cord_uid: qgib1cu4 IMPORTANCE: The spectrum of complications of COVID‐19 in children, including the effect of COVID‐19 on later viral infection, is not known. OBJECTIVE: To examine the features of children hospitalized for respiratory illness with history of prior COVID‐19. DESIGN: Retrospective observational case series at a single pediatric quaternary medical center in New York City. Data were obtained from review of medical records. PARTICIPANTS: Children with prior mild or asymptomatic COVID‐19 and no known risk factors for severe respiratory disease, who were hospitalized at our center for acute respiratory illness from October 2020 to May 2021, were reviewed. MAIN OUTCOMES AND MEASURES: Co‐morbidities, history of prior COVID‐19 symptoms, respiratory viral panel findings, acuity of illness, degree of respiratory decompensation based on support and interventions required, duration of hospitalization, and overall clinical course were assessed from the medical record. RESULTS: This study included 5 patients (median age, 4 years; age range: 0.8–9 years; 4 [80%] male). All had positive COVID‐19 serology, 1 (20%) had mild symptoms, while the others had no symptoms of prior Sars‐CoV‐2 infection, 3 (60%) had asthma, and the remaining had no co‐morbidities. All were admitted between April and May 2021. Two were re‐admitted for respiratory symptoms in the subsequent 3 months. CONCLUSIONS AND RELEVANCE: This case series describes a possible association between severe lower respiratory tract infection and prior mild COVID‐19 in children. Larger cohort studies describing the respiratory effects of prior COVID‐19 in children are needed. The COVID-19 pandemic is responsible for tremendous morbidity and mortality worldwide. Although COVID-19 vaccination implementation has begun, the Sars-CoV-2 virus continues to spread rampantly in different parts of the globe. To date, age has been considered a major factor in determining risk and prognosis with COVID-19 disease. While the rate of severe complications and death is significantly lower in children compared to adults, children are just as likely to be infected as adults [1] [2] [3] [4] [5] and the complete spectrum of short and long term complications is not well documented. In early 2020, multisystem inflammatory syndrome associated with COVID-19 (MIS-C) was described as a novel and severe complication in children and adolescents recovering from infection with Sars-CoV-2. 6 Many cases have been reported globally, but the underlying immune mechanisms are not understood. New York City was the initial epicenter of the COVID-19 pandemic in the United States. During the peak months of the pandemic, we had very few pediatric admissions to our children's hospital, which is a quaternary medical center in a large metropolitan region. In early 2021, as the numbers of new infections started to ebb, we observed children with no underlying chronic lung disease presenting with acute respiratory failure in the setting of infections with common and typically mild respiratory pathogens. The majority had asymptomatic or mild prior COVID-19 infection. It is not known if prior COVID-19 infection is associated with altered response to other respiratory viral infections that could explain these severe presentations. We present five cases of children with severe lower respiratory tract infections leading to hospital admission for acute respiratory failure. All of these children had prior mild or asymptomatic COVID-19 infection. For this retrospective case series, the study period was October 2020 to May 2021. Children less than 18 years of age admitted for respiratory distress in the setting of a non-Sars-CoV-2 viral infection were considered for this study. Children were included in the case series if they had a previous asymptomatic or mild infection with Sars-CoV-2 based on history and either nasal PCR or positive COVID-19 serology, and no other known factors for severe respiratory disease. Infections were considered asymptomatic when the parent reported absence of symptoms. Well controlled mild to moderate persistent asthma was not considered a significant risk factor for severe respiratory disease. COVID-19 serology was determined using the Elecsys ® Anti-SARS-CoV-2 immunoassay, which detects antibodies to the nucleocapsid antigen of SARS-CoV-2 with 100% (88.3%, 100%) sensitivity and 99.8% (99.7%, 99.9%) specificity. Clinical course, laboratory values, and imaging were obtained from the electronic medical record. The study was approved by the institutional review board of Columbia University Irving Medical Center under expedited review with a waiver of consent. A 10-month-old boy with no notable past medical history was referred to the emergency department (ED) by his pediatrician for fever, cough, difficulty breathing, hypoxia, and lethargy (Table 1) . His SpO2 was 73% in RA, and improved with supplemental oxygen via non-rebreather mask. On examination, he was cyanotic and in moderate respiratory distress, with coarse breath sounds and rhonchi bilaterally. His chest X-ray demonstrated hyperinflation, prominent interstitial markings, and patchy perihilar opacities. Respiratory viral panel was positive for respiratory syncytial virus (RSV) and adenovirus. White blood cell (WBC) and differential were normal. Procalcitonin and CRP were elevated, 0.73 ng/ml and 89.06 mg/L (8.9 × 10 4 µg/L), respectively. COVID-19 serology was positive with no history of symptomatic illness in the past. He was treated with ceftriaxone, bilevel positive airway pressure (BiPAP) and supplemental oxygen. Respiratory support was weaned completely and he was discharged home in 2 days. A 28-month-old boy with autism and moderate persistent asthma, well controlled on inhaled corticosteroids, presented with fever for 3 days, vomiting, cough and nasal congestion for 2 days, and worsening respiratory distress for 1 day (Table 1) . He was hospitalized once in the previous year for acute respiratory failure secondary to bronchospasm in the setting of Rhino/enteroviral (REV) infection. He had COVID-19 about 2 months before the current illness, in which he had fever, vomiting, and nasal congestion, but did not require hospitalization. In the ED, he was tachypneic, tachycardic, and his SpO 2 was 75% in room air. He was in moderate respiratory distress and had bilateral wheezing. Respiratory viral panel was positive for REV, and negative for Sars-CoV-2. Chest X-ray showed mild prominence of lung markings and no focal consolidation. WBC and differential were normal. Procalcitonin and CRP were elevated, 0.32 ng/ml and 74.41 mg/L (7.4 × 10 4 µg/L), respectively. COVID-19 serology was positive. He was treated with intermittent albuterol, ceftriaxone, BiPAP and supplemental oxygen, initially requiring FiO 2 1.0. Respiratory support, oxygen, and albuterol were gradually weaned and he was discharged home after 2 days with instructions to complete 5 days of prednisolone and continue low dose inhaled corticosteroids. He presented again 2 months later with fever, nasal congestion, decreased oral intake, and difficulty breathing and was admitted for status asthmaticus in the setting of REV infection. Chest X-ray demonstrated prominent lung markings and bilateral bronchial wall thickening. He was treated with continuous albuterol, IV methylprednisolone, and continuous positive airway pressure (CPAP) with supplemental oxygen. He was discharged home after 3 days. A 3-year-old boy with no notable past medical history presented to the ED after 1 day of cough, nasal congestion, fever, and increased work of breathing (Table 1) . On initial examination, he had severe respiratory distress, oxygen saturation (SpO 2 ) of 85% in room air, diminished aeration, wheezing, and prolonged exhalation. Respiratory viral panel was positive for REV, and negative for Sars-CoV-2. COVID-19 antibodies were present, with no history of a prior symptomatic illnesses. Chest X-ray demonstrated multifocal opacities. Total WBC was normal, and differential demonstrated 90% neutrophils and 6% lymphocytes. Procalcitonin and CRP were A 5-year-old girl with allergies and well controlled asthma with no prior hospitalizations was transferred to our intensive care unit after cardiac arrest and resuscitation ( In this case series, we describe five children who were hospitalized for severe respiratory symptoms secondary to a viral lower re- CoV-2 infection, and "Long COVID," is described in adults with widely varying frequency. [7] [8] [9] [10] [11] [12] It is a protracted constellation of symptoms that persist after initial COVID-19 illness, including those who did not require hospitalization. [13] [14] [15] Common symptoms include fatigue, shortness of breath, chest pain, and cough. 9, 11, 16 There is some evidence to suggest that female sex is a risk factor for PACS, 17 but this has not been noted consistently amongst all cohorts. 9, 11, 18 Several studies have described postacute COVID-19 symptoms in children and young adults, indicating that long COVID symptoms are not limited to the adult population. [19] [20] [21] [22] [23] In these cohorts, the pre- Stephanie Lovinsky-Desir https://orcid.org/0000-0003-2272-4387 Distinct characteristics of COVID-19 infection in children SARS-CoV-2 (COVID-19): what do we know about children? A systematic review COVID-19 under 19: a meta-analysis Clinical manifestations of children with COVID-19: a systematic review Clinical characteristics of COVID-19 in children: a systematic review COVID-19 and multisystem inflammatory syndrome in children and adolescents Post-acute sequelae of SARS-CoV-2 infection: caring for the 'long-haulers' Post-acute COVID-19 syndrome Late conditions diagnosed 1-4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data-United States Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network -United States Symptoms and functional impairment assessed 8 months after mild COVID-19 among health care workers Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study Preliminary evidence on long COVID in children Post-acute COVID-19 outcomes in children with mild and asymptomatic disease Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study The kids are not alright: a preliminary report of Post-COVID syndrome in university students Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection Pulmonary sequelae of pediatric patients after discharge for COVID-19: an observational study Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission Prevalence of SARS-CoV-2 antibodies in New York City adults Delayed seasonal RSV surge observed during the COVID-19 pandemic The interseasonal resurgence of respiratory syncytial virus in australian children following the reduction of coronavirus disease 2019-related public health measures Severe respiratory viral infections in children with history of asymptomatic or mild COVID-19